This year WOMEN IN NEPHROLOGY is celebrating 40 Years of WINing: A Legacy of Leadership! Team Vera is proud to sponsor this important organization and its goal of developing and providing mentors for women in the field of nephrology. Thank you Marissa Quinones, Pharm.D. for representing our team at the WIN Leadership Conference!
Vera Therapeutics, Inc.
Biotechnology Research
Brisbane, California 7,739 followers
We are a clinical-stage biotechnology company developing treatments that transform patients’ lives.
About us
Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing treatments for immunological and inflammatory diseases that improve patients’ lives.
- Website
-
http://www.veratx.com
External link for Vera Therapeutics, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Brisbane, California
- Type
- Public Company
Locations
-
Primary
8000 Marina Blvd
120
Brisbane, California 94005, US
Employees at Vera Therapeutics, Inc.
Updates
-
Today we provided a business update and reported Q1 financial results. Read the full release here: https://lnkd.in/ehUnQjz6 $VERA
-
Our founder and CEO Marshall Fordyce, M.D. recently returned to Biotech2050 to discuss Vera's evolution to where we are today, with a promising lead clinical program in #IgANephropathy and the potential to explore additional diseases where we may transform the standard of care. Thank you Rahul Chaturvedi for the opportunity to reflect on our journey and key insights we gained along the way. Listen to the full episode here: https://lnkd.in/eqHFpe4B
Delighted to unveil the newest #Biotech 2050 episode with Marshall Fordyce, M.D. Fordyce, the innovative Founder & CEO of Vera Therapeutics, Inc.! 🎙️ In this episode, Host Rahul Chaturvedi joins Marshall as they delve into his transformative journey from physician to biotech entrepreneur, offering invaluable perspectives on the biotech industry. Discover how Vera Therapeutics pivoted to focus on IG nephropathy and their groundbreaking work with atacicept, a promising B-cell modulator. Key highlights include: 🔹 The importance of scientific rigor and adaptability 🔹 Navigating the biotech landscape 🔹 Future outlook on autoimmune disease treatments Whether you're an aspiring entrepreneur or a seasoned professional, Marshall's insights on maintaining a lean operating model and driving innovation are a must-listen. 🎧 Tune in now and get inspired by the future of autoimmune disease treatments: https://lnkd.in/eaq7isNN #Biotech #Autoimmune #Innovation #Healthcare #BiotechBreakthroughs #Podcast #MedicalResearch #ClinicalTrials #DrugDevelopment #HealthcareInnovation #Entrepreneurship
-
We're proud and honored to support World Kidney Day's mission to raise awareness and shift the treatment landscape for kidney disease worldwide!
Today, we want to give a special thanks to Vera Therapeutics, Inc. for supporting our World Kidney Day campaign. Their contribution helps us raise crucial awareness about kidney health. #WorldKidneyDay #KidneyHealthForAll
-
Last weekend, Team Vera attended #SPARK2024, a symposium organized by and for patients with #IgANephropathy through The IgA Nephropathy Foundation. Alongside the #IgAN community of patients and caregivers, we learned about individual experiences and what it means to live with this rare disease. Hear from our Founder and CEO, Marshall Fordyce, M.D., to learn more about key themes from the conference and why this is the highlight of our year. Vera is dedicated to incorporating insights from patients to develop treatments designed to improve patient outcomes and overall quality of life.
-
Team Vera is thrilled to be at #SPARK2024 in Austin, Texas, July 26-28. We look forward to joining patients, clinicians, scientists, and educators to support the advancement of treatment for #IgANephropathy (#IgAN). Come check out our table at the conference and connect with the broader kidney disease community. We look forward to seeing you there! To learn more about the SPARK conference, a 2-day symposium hosted by the The IgA Nephropathy Foundation, click here: https://iganspark.org
-
The #IgANephropathy (#IgAN) treatment landscape has transformed over the last few years with new approved therapies and others in late-stage clinical development. The recently published MedNous article, authored by our SVP of Medical Affairs, Kerry Cooper, discusses Vera’s potentially first-to-market self-administered B cell modulation therapy within the evolving IgAN landscape. Read the full article to learn more! Published in the June edition of MedNous, a publication of Evernow Publishing Ltd.
-
Today we announced the appointment of David (DJ) Johnson as Chief Operating Officer at Vera. David's rich commercial and operational experience is a valuable addition to our executive team and will help drive the advancement of our clinical development programs. Read the full press release here: https://lnkd.in/e5n6jd96 $VERA
-
On Sunday, Team Vera joined the National Kidney Foundation to sponsor the 2024 Northern California Kidney Walk at PayPal Park. This event brought the Northern California community together to fundraise for those affected by kidney disease. We were proud to walk alongside the kidney community and share the goal of achieving kidney health for all, one step at a time. #kidneydisease #IgANephropathy #IgAN
-
Team Vera made a splash at #APCN2024, where we sponsored a symposium describing the unmet need in #IgAN, insights into the role of BAFF and APRIL in IgAN pathogenesis, and emerging clinical data for atacicept, our investigational therapeutic. Visit veratx.com to learn more about our clinical program. #IgANephropathy